Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder

Robert Schnoll, E. Paul Wileyto, Anna Marika Bauer, Erica Fox, Frank Leone, Caryn Lerman, Rachel F. Tyndale, Tony P. George, Larry Hawk, Paul Cinciripini, Mackenzie Quinn, Janelle Purnell, Jane Hatzell, Brian Hitsman

Research output: Contribution to journalArticlepeer-review

Abstract

Background and Objectives: Persons with current or past major depressive disorder (MDD) vs those without have higher smoking rates. The nicotine metabolite ratio (NMR) represents variation in the rate of nicotine metabolism and has been associated with smoking behaviors and response to tobacco treatments. We compared NMR between smokers with current or past MDD (MDD+) vs smokers without MDD (MDD−). We also assessed correlates of NMR and compared withdrawal and craving between MDD+ and MDD− smokers. Methods: Using baseline data from two clinical trials and propensity score weighting based on sex, race, body mass index, and smoking rate, we compared NMR between MDD+ (N = 279) and MDD− (N = 1575) smokers. We also compared groups on and nicotine withdrawal and craving. Results: Mean NMR (β = −.02, 95% confidence interval [CI]: −0.05 to 0.01, P =.13) and the distribution of smokers across NMR quartiles (odds ratio [OR] = 0.76, 95% CI: 0.50 to 1.16, P =.21) were similar between MDD+ and MDD− samples. This relationship was not affected by antidepressant medication. In the MDD+ sample, African Americans had significantly lower mean NMR, while older smokers and smokers with lower education had higher mean NMR (Ps <.05). MDD+ smokers had significantly higher withdrawal and craving than MDD− smokers (Ps <.05). Discussion and Conclusions: While variability in NMR may not explain differences in smoking rates between MDD+ and MDD− smokers, MDD+ smokers report increased withdrawal and craving. Scientific Significance: In this first study to assess NMR among MDD+ smokers, the findings underscore the need to address withdrawal and craving within smoking cessation treatments for those with MDD. (Am J Addict 2021;00:00–00).

Original languageEnglish (US)
Pages (from-to)382-388
Number of pages7
JournalAmerican Journal on Addictions
Volume30
Issue number4
DOIs
StatePublished - Jul 2021

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder'. Together they form a unique fingerprint.

Cite this